Businesses
Here's a look at documents from U.S. and international businesses
Featured Stories
Motorola Solutions Helps Victorian Search and Rescue Dog Teams Perform Safe and Successful Missions
SCHAUMBURG, Illinois, March 14 -- Motorola Solutions issued the following news release:
* * *
Motorola Solutions Helps Victorian Search and Rescue Dog Teams Perform Safe and Successful Missions
Robust radio technology supports interagency collaboration in the state's most rugged and remote terrain
*
MELBOURNE, Australia - Motorola Solutions (NYSE: MSI) has announced the addition of two Victorian volunteer search and rescue dog organisations to the Victorian Radio Network (VRN), supporting rescue missions in challenging and isolated areas.
Australian Search and Rescue K9 (ASAR-K9) and Search
... Show Full Article
SCHAUMBURG, Illinois, March 14 -- Motorola Solutions issued the following news release:
* * *
Motorola Solutions Helps Victorian Search and Rescue Dog Teams Perform Safe and Successful Missions
Robust radio technology supports interagency collaboration in the state's most rugged and remote terrain
*
MELBOURNE, Australia - Motorola Solutions (NYSE: MSI) has announced the addition of two Victorian volunteer search and rescue dog organisations to the Victorian Radio Network (VRN), supporting rescue missions in challenging and isolated areas.
Australian Search and Rescue K9 (ASAR-K9) and Searchand Rescue Dogs Australia (SARDA) can now use Motorola Solutions' APX 8000 portable two-way radios to communicate directly with the state's primary emergency services on shared channels, improving the speed and safety of rescue operations.
"Our dogs are trained to search through thick bushland to locate missing persons, often in highly challenging and time-critical situations," said Angelica Suarez, President of Australian Search and Rescue K9.
"These new radios enable us to communicate securely with police and other emergency services, significantly improving safety for our members and our effectiveness in bringing loved ones home."
Representatives from Victorian emergency services and Motorola Solutions joined dedicated search and rescue dog rescue teams at Australian Search and Rescue K9 headquarters to celebrate the donation of the new radios.
"Providing these exceptional search and rescue dog teams and public safety agencies with resilient communications helps them to work safely and efficiently, coordinating their responses when it matters most," said Con Balaskas, managing director, Motorola Solutions Australia and New Zealand. "This collaboration has already proven its value; in one recent search, rescue dog teams located critical items belonging to a missing woman, leading police to find her safe and well at a remote location."
The addition of search and rescue dogs to the VRN follows the Victorian government's 10-year contract extension with Motorola Solutions to maintain and enhance emergency communications across the state.
* * *
About Motorola Solutions | Solving for safer
Safety and security are at the heart of everything we do at Motorola Solutions. We build and connect technologies to help protect people, property and places. Our solutions foster the collaboration that's critical for safer communities, safer schools, safer hospitals, safer businesses, and ultimately, safer nations. Learn more about our commitment to innovating for a safer future for us all at www.motorolasolutions.com.
* * *
Original text here: https://www.motorolasolutions.com/newsroom/press-releases/motorola-solutions-helps-victorian-search-and-rescue-dog-teams.html
[Category: BizTelecommunications]
Littler: Policy Week in Review - March 13, 2026
SAN FRANCISCO, California, March 14 -- Littler, a law firm, issued the following news:
* * *
Policy Week in Review - March 13, 2026
Congressional and Administrative News
At a Glance
The Policy Week in Review, prepared by Littler's Workplace Policy Institute (WPI), sets forth WPI's updates on federal legislation, regulations, and congressional activity affecting the workplace.
By Shannon Meade, Jim Paretti, Alex MacDonald, and Maury Baskin
Industry Groups Petition NLRB for Rulemakings
Several industry groups submitted rulemaking petitions to the National Labor Relations Board (NLRB) this
... Show Full Article
SAN FRANCISCO, California, March 14 -- Littler, a law firm, issued the following news:
* * *
Policy Week in Review - March 13, 2026
Congressional and Administrative News
At a Glance
The Policy Week in Review, prepared by Littler's Workplace Policy Institute (WPI), sets forth WPI's updates on federal legislation, regulations, and congressional activity affecting the workplace.
By Shannon Meade, Jim Paretti, Alex MacDonald, and Maury Baskin
Industry Groups Petition NLRB for Rulemakings
Several industry groups submitted rulemaking petitions to the National Labor Relations Board (NLRB) thisweek. A Petition filed on March 12 requests that the Board commence a rulemaking proceeding to protect secret ballot elections under the National Labor Relations Act (NLRA). The petition urges the Board to promulgate a rule that would "eliminate current confusion and inconsistency and specify the circumstances under which the Board may, consistent with Gissel, exercise its remedial discretion to issue and seek enforcement of a bargaining order, reaffirming the Act's preference for secret-ballot-elections." Petitioners argue the rule would promote predictability, protect employee free speech, and confine bargaining orders to their proper remedial function.
Another Petition filed on March 12 requests that the Board initiate a rulemaking to reconsider the lawfulness of the standard previously adopted by the Board, which held that employer-required meetings ("captive audience meetings"), during which the employer discusses unionization with their employees, violates the NLRA and the First Amendment.
These Petitions follow the Rulemaking Petition filed by industry groups on February 11 urging the Board to adopt a proposed rule for determining independent contractor status under the NLRA. That petition argued that such a rule would restore the certainty and clarity provided by application of the common-law test as set forth in the Board's decision in SuperShuttle and that it would better align with judicial precedent and the current administration's views.
NLRB Declines to Overrule Ex-Cell-O
In a closely watched development, the National Labor Relations Board has declined to overrule Ex Cell O Corp., 185 NLRB 107 (1970), preserving a 56 year old framework that limits remedies when an employer refuses to bargain to test a union's certification and an appeals court ultimately upholds the certification. The decision came in the Board's ruling in Longmont United Hospital on February 26, 2026. For Littler's analysis on what employers should know, read here.
Senate Republicans Raise Challenges with Previous Administration's Proposed Heat Safety Rule
Senate Health, Education, Labor, and Pensions (HELP) Committee Chair Bill Cassidy (R-LA) and 15 Republican Senators sent a letter to U.S. Department of Labor Secretary Chavez-DeRemer urging the Department to consider, as the rulemaking continues, a variety of concerns raised by constituents with the previous administration's "one-size-fits-all" proposed rule.
Chair Cassidy (R-LA) Requests Information on College Athletics
Following the March 10 Senate HELP Committee roundtable addressing the "The New Era of College Sports: Finding a Stable Path Forward," Chair Cassidy (R-LA) issued an RFI on college athletics requesting information from stakeholders on employment considerations, among other items.
* * *
Authors
Shannon Meade
Executive Director, Workplace Policy Institute
Washington, D.C.
* * *
James A. Paretti
Shareholder
Washington, D.C.
* * *
Alexander T. MacDonald
Shareholder
Washington, D.C.
* * *
Maury Baskin
Shareholder
Washington, D.C.
* * *
Original text here: https://www.littler.com/news-analysis/asap/policy-week-review-march-13-2026
[Category: BizLaw/Legal]
Inside BuzzFeed's Secret Lab: Three Apps, A New Company, And A Bet On The Future Of The Internet
NEW YORK, March 14 -- BuzzFeed, a digital media company, issued the following news on March 13, 2026:
* * *
Inside BuzzFeed's Secret Lab: Three Apps, A New Company, And A Bet On The Future Of The Internet
For the past year, a small team has been quietly developing a new kind of company. Today at SXSW, Branch Office came out of stealth to preview the first two of many apps.
AUSTIN, TX - BuzzFeed, Inc. (Nasdaq: BZFD) today unveiled Branch Office, a new spinoff company that has been secretly developing a slate of apps designed to reinvent how people connect on the internet. The first two are launching
... Show Full Article
NEW YORK, March 14 -- BuzzFeed, a digital media company, issued the following news on March 13, 2026:
* * *
Inside BuzzFeed's Secret Lab: Three Apps, A New Company, And A Bet On The Future Of The Internet
For the past year, a small team has been quietly developing a new kind of company. Today at SXSW, Branch Office came out of stealth to preview the first two of many apps.
AUSTIN, TX - BuzzFeed, Inc. (Nasdaq: BZFD) today unveiled Branch Office, a new spinoff company that has been secretly developing a slate of apps designed to reinvent how people connect on the internet. The first two are launchingnow. More are coming this year.
Branch Office operates independently, with its own founders, its own mandate, and a product philosophy built for a world where AI has blurred the lines between software and content. BuzzFeed saw a gap no one else was filling, and built a dedicated company, quietly, to move fast enough to actually fill it.
"We're accelerating into an era of infinite fake news, slop, personalization bubbles, and cuts at the organizations that actually care about content," said Jonah Peretti. "We need a solution. Branch Office is that solution."
IN THE LAB
BuzzFeed has been running AI experiments for years -- a game where you raised a nepo baby, a chatbot that lets you attempt to talk a Karen down in a Starbucks line. Through hundreds of projects the team learned what AI could do when it wasn't trying to replicate existing models of static content production, but building totally new experiences that would not have been possible before the advent of GenAI. While most social media companies are using AI to keep people isolated in their own algorithmic feeds, BuzzFeed's projects were built on the premise that creativity and engagement can bring people closer together, help them connect with their friends.
THE PHILOSOPHY: NINTENDO, NOT BIG TECH
Led by founder Bill Shouldis, Branch Office operates with a clear vision: treat software as a creative medium. Build fast. Iterate constantly. Let real communities, real culture, and genuine taste shape what gets made.
The guiding philosophy comes from an unlikely place: Nintendo. The gaming giant's principle of "lateral thinking with withered technology," taking maximum creativity out of what already exists, is Branch Office's north star. We don't need to build our own foundational models or compete with Big Tech. We just ask one question: what's already here, and how do we make it genuinely fun?
When Branch Office looked at the market, they saw two camps: companies building AI to replace humans, and companies building AI to simulate them. Branch Office is doing neither.
"Most companies are using AI to replace human creativity," said Bill Shouldis, Founder, Branch Office. "We're leveraging it to connect people."
THE APPS
1. CONJURE -- COMING SOON (iOS APP STORE, US & JAPAN)
Every day, Conjure sends you a summons: a subject to go photograph. You submit your photo as an offering. Something on the other end accepts it. Or it doesn't. No explanation. The lore builds over time, and entirely unlike anything else in the App Store -- a daily ritual designed to pull people out of their feeds and into the world.
As Shouldis said on stage, "It solves the eternal problem for people who wanted BeReal to be in the X-Files universe."
2. BF ISLAND -- IN PRIVATE BETA NOW (iOS APP STORE, US)
Your group chat has its own language, the callbacks, the bits, the references that only land with the seven people in the thread. BF Island lets you visualize all of it, drop in a photo, riff on it, spin it into something that makes your friends lose it. No algorithm. No followers. Just your people.
3. QUIZ PARTY -- COMING SOON A social quiz app. You find a quiz, you take it, you get your result, and then you share it with your friends. Everyone in the 'quiz party' sees each other's results and you roast each other in the chat. People have been doing this with BuzzFeed quizzes for years -- screenshotting, texting, posting -- but now we're building that behavior directly into the product, so it's easier, it's tighter, and it brings more people in.
THE BET AGAINST THE ALGORITHM
"The Internet disrupted distribution. Now AI is disrupting production," said Peretti. "When you don't have a vision for the content, you get a feed of slop. The value has moved -- it's about community, culture, and taste. That's what Big Tech can't automate. Software is the new content."
Branch Office: branchoffice.studio/email
Conjure: whatwillyouconjure.com
BF Island: bfisland.com
About BuzzFeed, Inc.
BuzzFeed, Inc. is home to the best of the Internet. Across pop culture, entertainment, shopping, food and news, our brands drive conversation and inspire what audiences watch, read, and buy now - and into the future. Born on the Internet in 2006, BuzzFeed is committed to making it better: providing trusted, quality, brand-safe news and entertainment to hundreds of millions of people; making content on the Internet more inclusive, empathetic, and creative; and inspiring our audience to live better lives.
* * *
Original text here: https://www.buzzfeed.com/buzzfeedpress/inside-buzzfeeds-launches-branch-office-ai-incubator
[Category: BizMedia]
IHeartMedia Names Freya Skye as Latest 'On the Verge' Artist
SAN ANTONIO, Texas, March 14 -- iHeartMedia issued the following news release:
* * *
iHeartMedia Names Freya Skye as Latest 'On the Verge' Artist; World Premieres New Singles from Eagles, Kane Brown, Carly Pearce ft. Riley Green
NEW YORK - iHeartMedia recently highlighted new music and artists alike with special programming, including new 'On The Verge' artists and World Premiere debuts.
Earlier this year, iHeartMedia named Freya Skye the latest 'On The Verge' CHR artist with her single "Silent Treatment." iHeartMedia's 'On The Verge' program helps build awareness for up-and-coming artists
... Show Full Article
SAN ANTONIO, Texas, March 14 -- iHeartMedia issued the following news release:
* * *
iHeartMedia Names Freya Skye as Latest 'On the Verge' Artist; World Premieres New Singles from Eagles, Kane Brown, Carly Pearce ft. Riley Green
NEW YORK - iHeartMedia recently highlighted new music and artists alike with special programming, including new 'On The Verge' artists and World Premiere debuts.
Earlier this year, iHeartMedia named Freya Skye the latest 'On The Verge' CHR artist with her single "Silent Treatment." iHeartMedia's 'On The Verge' program helps build awareness for up-and-coming artiststhrough its radio airplay and historically, all 'On The Verge' artists have charted in the top 30, with more than half landing in the top 10 and over a third claiming the No. 1 chart slot.
This week, legendary rock band Eagles' "Carol" had a World Premiere debut on March 10 across all iHeartRadio Classic Hits stations; Carly Pearce and Riley Green's "If I Don't Leave I'm Gonna Stay" had a World Premiere debut on March 12 across all iHeartCountry stations; and Kane Brown's "Woman" had a World Premiere debut on March 13 across all iHeartCountry stations.
For the latest news, music fans can download the iHeartRadio app; follow iHeartRadio on Instagram, TikTok, Twitter/X, Facebook and YouTube; and visit iHeartRadio.com.
* * *
About iHeartMedia, Inc.
iHeartMedia, Inc. [Nasdaq: IHRT] is the leading audio media company in America, with nine out of ten Americans listening to iHeart broadcast radio in every month. iHeart's broadcast radio assets alone have a larger audience in the U.S. than any other media outlet and over four times the ad-enabled audience of the largest digital only audio service. iHeart is the largest podcast publisher according to both Podtrac and Triton, with more downloads than the next two podcast publishers combined, has the most recognizable live events across all genres of music, has the number one social footprint among audio players, has the highest-reach and most engaged influencers, and is the only fully integrated audio ad tech solution across broadcast, streaming and podcasts. The company continues to leverage its strong audience connection and unparalleled consumer reach to build new platforms, products and services. Visit iHeartMedia.com for more company information.
* * *
Original text here: https://www.iheartmedia.com/press/iheartmedia-names-freya-skye-latest-verge-artist-world-premieres-new-singles-eagles-kane
[Category: BizMedia]
GSK's RSV Vaccine, Arexvy, Approved in US for Expanded Age Indication in Adults Aged 18-49 Years at Increased Risk
LONDON, England, March 14 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on March 13, 2026:
* * *
GSK's RSV vaccine, Arexvy, approved in US for expanded age indication in adults aged 18-49 years at increased risk
- In the US, an estimated 21 million adults under 50 have at least one risk factor for severe RSV infection/1*
*
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has expanded the approved age indication of Arexvy (Respiratory Syncytial Virus vaccine, [adjuvanted]) to adults aged 18 to 49 years
... Show Full Article
LONDON, England, March 14 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on March 13, 2026:
* * *
GSK's RSV vaccine, Arexvy, approved in US for expanded age indication in adults aged 18-49 years at increased risk
- In the US, an estimated 21 million adults under 50 have at least one risk factor for severe RSV infection/1*
*
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has expanded the approved age indication of Arexvy (Respiratory Syncytial Virus vaccine, [adjuvanted]) to adults aged 18 to 49 yearsat increased risk for lower respiratory tract disease (LRTD) caused by RSV. GSK's RSV vaccine was previously approved in the US for the prevention of RSV-related LRTD in adults aged 60 and older, and adults aged 50-59 at increased risk for LRTD caused by RSV. This vaccine is not for use in pregnant individuals.
Sanjay Gurunathan, GSK Head of Vaccines and Infectious Diseases Research and Development, said: "This age expansion can help address a significant medical need for adults in the United States at higher risk of severe RSV disease due to certain underlying conditions, and help ease pressure on the healthcare system. We are proud of this latest step in our strategy to bring RSV prevention to broader adult populations."
The annual RSV burden among US adults aged 18-49 years is about 17,000 hospitalisations, 277,000 emergency department admissions, and 1.97 million outpatient visits.2 Most hospitalisations in younger adults occur in those with chronic medical conditions which place them at increased risk for severe RSV disease (e.g. chronic cardiopulmonary, kidney or renal disease, obesity and diabetes)./2
The FDA's decision was supported by data from a Phase IIIb trial (NCT06389487) demonstrating a non-inferior immune response compared to adults aged 60 years and above./3 Vaccine efficacy was demonstrated in the earlier Phase III trial (NCT04886596)./4 The safety profile was consistent with findings from the broader Phase III programme that supported the initial US approval, with the most common adverse events being injection site pain, fatigue, myalgia, headache, and arthralgia within four days of vaccination./3
GSK continues to advance regulatory submissions for its RSV vaccine across multiple geographies to expand availability and support long-term growth objectives.
About GSK's RSV vaccine
Respiratory Syncytial Virus vaccine (adjuvanted) contains recombinant RSV glycoprotein F stabilised in the prefusion conformation (RSVPreF3). This antigen is combined with GSK's proprietary AS01E adjuvant before administration.
The use of this vaccine should be in accordance with official recommendations. As with any vaccine, a protective immune response may not be elicited in all vaccinees.
The vaccine has been approved for the prevention of RSV-LRTD in individuals 60 years of age and older in 70 countries. In addition, it is approved for use in individuals aged 50-59 who are at increased risk due to certain underlying medical conditions in more than 60 countries. In the European Economic Area it is approved for adults aged 18 years and older.
The GSK proprietary AS01 adjuvant system contains STIMULON QS-21 adjuvant licensed from Antigenics LLC, a wholly owned subsidiary of Agenus Inc. STIMULON is a trademark of SaponiQx Inc., a subsidiary of Agenus.
Please refer to the full US Prescribing Information (PI) for important dosage, administration, and safety information: https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Arexvy/pdf/AREXVY.PDF
* * *
About the NCT06389487 trial
NCT06389487 is a Phase IIIb, open-label multi-country immunogenicity trial to evaluate the non-inferiority of the immune response and evaluate safety in participants aged 18-49 at increased risk for lower respiratory tract disease (LRTD) caused by RSV (n=426), compared to participants aged 60 years and above (n=429) after a single dose of GSK's RSV vaccine. An additional cohort, of 603 participants aged 18-49, was followed up for adverse events separate to safety follow up of the initial cohort. A total of 1,458 participants were enrolled across 52 locations in six countries, including 16 US sites.
The study assessed the immune response in participants aged 18-49 with pre-defined stable chronic diseases leading to an increased risk for RSV disease, compared to those aged 60 years and above. The trial's primary endpoints were RSV-A and RSV-B neutralisation titres of adults aged 18 - 49 years at one month after the vaccine administration compared to adults aged 60 and older. There were also safety and immunogenicity secondary and tertiary endpoints. Safety and reactogenicity data were consistent with results from the initial data read out in NCT04886596. The most common local adverse event was pain. The most common systemic adverse events were myalgia, fatigue and headache, which were largely transient and mild to moderate in intensity.
* * *
About RSV in adults
RSV is a common contagious virus affecting the lungs and breathing passages and impacts an estimated 64 million people of all ages globally every year.5 Adults can be at increased risk for RSV disease due to certain comorbidities, immune compromised status, or advanced age.6 RSV can exacerbate certain conditions, including COPD, asthma, and chronic heart failure and can lead to severe outcomes, such as pneumonia, hospitalisation, and death.6 Compared to children, adults hospitalised for RSV are at a higher risk of severe complications, require more costly treatments, have a higher fatality rate, and the true number of RSV-related cases is likely underestimated due to lack of routine testing./7,8,9,10
* * *
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.
* * *
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2025.
* * *
Footnotes
*/ Self-reported diagnoses of risk factors collected via the National Health and Nutrition Examination Survey (NHANES) in US adults 20-49 years of age. The figure of 21.3 million is based on 17.0% of a total 125,255,765 adults 20-49 who had at least one risk factor (including congestive heart failure, coronary heart disease, stroke, angina, myocardial infarction, chronic obstructive pulmonary disease, asthma, diabetes, liver disease and/or renal disease) for severe RSV disease
/ Based on a systematic review and meta-analysis of studies describing population-based rates of medically attended RSV among US adults (n=14 articles published between 2007 and 2021). Estimates were based on RSV as detected by RT-PCR of NP or nasal swabs and then adjusted for under detection. Age-specific US census population estimates were applied to project the expected number of annual cases.
* * *
References:
1./ Horn et al, "Characteristics Associated with the Presence of One or More Risk Factors for Severe Respiratory Syncytial Virus Disease among Adults in the United States", poster presented at ID Week 2024 [available on demand: P691 - DV-009542.pdf]
2./ McLaughlin JM, et al. Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis. Page 17 Supplementary Data. Open Forum Infect Dis. 2022 Jun 17;9(7):ofac300. doi: 10.1093/ofid/ofac300. PMID: 35873302; PMCID: PMC9301578.
3./ Clinicaltrials.gov. A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above. Available at: https://clinicaltrials.gov/study/NCT06389487. Last accessed: March 2026.
4./ Clinicaltrials.gov. Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above. Available at: https://clinicaltrials.gov/study/NCT04886596. Last accessed: March 2026.
5./ National Institute of Allergy and Infectious Diseases, Respiratory Syncytial Virus (RSV). Available at: https://www.niaid.nih.gov/diseases-conditions/respiratory-syncytial-virus-rsv. Last accessed: March 2026.
6./ Falsey, A, R et al. Respiratory syncytial virus infection in elderly and high-risk adults, in New Engl J Med 2005; 352:1749-59. doi: 10.1056/NEJMoa043951.
7./ Alfano F, et al. Respiratory Syncytial Virus Infection in Older Adults: An Update. Drugs Aging. 2014;41:487-505.
8./ Niekler P, et al. Hospitalizations due to respiratory syncytial virus (RSV) infections in Germany: a nationwide clinical and direct cost data analysis (2010-2019). Infection. 2024;52(5):1715-1724.
9./ Gunen H, et al. Key Challenges to Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Southeast Asia, the Middle East, and North Africa: An Expert Perspective. Adv Ther. 2024;41(11):4312-4334.
10./ Grace M, et al. Economic burden of respiratory syncytial virus infection in adults: a systematic literature review. J Med Econ. 2023;26(1):742-759.
* * *
Original text here: https://www.gsk.com/en-gb/media/press-releases/gsk-s-rsv-vaccine-arexvy-approved-in-us-for-expanded-age-indication-in-adults-aged-18-49-years-at-increased-risk/
[Category: BizPharmaceuticals]
Brian O'Shaughnessy Interviewed by Law360 on 'Skinny Label' Case
CINCINNATI, Ohio, March 14 -- Dinsmore and Shohl, a law firm, issued the following news release:
* * *
Brian O'Shaughnessy Interviewed by Law360 on 'Skinny Label' Case
After Dinsmore's intellectual property team filed an amicus brief with the Supreme Court of the United States on behalf of the Licensing Executives Society (USA & Canada), Inc. (LES), partner Brian O'Shaughnessy was interviewed by Law360 about the case.
The brief was submitted in Hikma Pharmaceuticals USA Inc., et al. v. Amarin Pharma, Inc., et al., which centers on the pleading standard applicable when a generic drugmaker is
... Show Full Article
CINCINNATI, Ohio, March 14 -- Dinsmore and Shohl, a law firm, issued the following news release:
* * *
Brian O'Shaughnessy Interviewed by Law360 on 'Skinny Label' Case
After Dinsmore's intellectual property team filed an amicus brief with the Supreme Court of the United States on behalf of the Licensing Executives Society (USA & Canada), Inc. (LES), partner Brian O'Shaughnessy was interviewed by Law360 about the case.
The brief was submitted in Hikma Pharmaceuticals USA Inc., et al. v. Amarin Pharma, Inc., et al., which centers on the pleading standard applicable when a generic drugmaker isaccused of induced patent infringement when it uses a "skinny label" that carves out a patented use, yet still refers to its product as a "generic version."
The article reads, "The Federal Circuit's decision in the Hikma case was clear and consistent with precedent, he (Brian) said, and affirming it will maintain clarity in the law. But if the justices reverse or set new standards, he added, they would be 'throwing us all into a bit of uncertainty as to what's expected going forward.'" LES urged the Court to proceed cautiously as any change will affect patent owners and implementers in all disciplines.
Find the full article from Law360 here (https://www.law360.com/articles/2450548/justices-advised-to-keep-law-clear-in-skinny-label-case).
* * *
Original text here: https://www.dinsmore.com/quotes-mentions/brian-oshaughnessy-interviewed-by-law360-on-skinny-label-case/
[Category: BizLaw/Legal]
Accenture Announces Reinvention Services Leadership
NEW YORK, March 14 -- Accenture, a global professional services company, presented the following news release on March 13, 2026:
* * *
Accenture Announces Reinvention Services Leadership
Accenture (NYSE: ACN) today announced its new leadership team for Reinvention Services, which is led by Manish Sharma, Accenture's Chief Strategy and Services Officer. These leaders are part of the company's implementation of a new design for Reinvention Services that will enable Accenture to create more leading solutions faster and embed data and AI more easily into its solutions and delivery. These changes
... Show Full Article
NEW YORK, March 14 -- Accenture, a global professional services company, presented the following news release on March 13, 2026:
* * *
Accenture Announces Reinvention Services Leadership
Accenture (NYSE: ACN) today announced its new leadership team for Reinvention Services, which is led by Manish Sharma, Accenture's Chief Strategy and Services Officer. These leaders are part of the company's implementation of a new design for Reinvention Services that will enable Accenture to create more leading solutions faster and embed data and AI more easily into its solutions and delivery. These changesare effective March 31, 2026.
Accenture is organizing its services around how its clients operate and will bring its clients end-to-end solutions, including with its ecosystem, through seven units called Reinvention Partners. Reinvention Partners are responsible for helping clients reinvent. The Reinvention Partners and their leaders are:
* Cybersecurity, led by Harpreet Sidhu, which will help clients reinvent cyber-resilience and value through trust-building defenses, protecting enterprises, managing risk and enabling emerging technologies.
* Digital Core, led by Ajoy Menon, which will help clients reinvent their digital foundations--including technology strategy and architecture, data and AI, modernizing and managing applications, infrastructure, data and cloud.
* Finance, led by Arundhati Chakraborty, which will help clients reinvent financial performance by supporting the CFO agenda--driving best-in-class performance and delivering insights and benchmarking across the enterprise. Chakraborty will also lead Accenture's practice helping clients create global capability centers.
* Industry and Enterprise, led by Muqsit Ashraf, which will help clients reinvent core industry value chains and drive end to end, cross functional reinvention to deliver growth and long term value.
* Song, led by Ndidi Oteh, which will help clients reinvent how they grow by focusing on the end-to-end customer agenda, bringing together customer growth strategy, marketing, sales, service, commerce, design, digital products, data and AI to create customer-led growth.
* Supply Chain and Engineering, led by Tracey Countryman, which will help clients leverage AI and digital technologies across product and asset lifecycles to build competitive advantage.
* Talent, led by Karalee Close, which will help clients reinvent how people and organizations work--delivering leadership, talent, operating models and change to accelerate the workforce agenda.
The new design also includes three Reinvention Engines, which are how Accenture will develop stronger, more specialized skills; the most AI-enabled ways of delivering its services; cutting-edge innovation, and the most advanced tools and methods. Together, the Reinvention Engines will work as an elite university, the world's best innovation lab and a powerhouse of industrialization all rolled into one.
While the Reinvention Partners are where Accenture helps its clients reinvent, the Reinvention Engines are where Accenture reinvents itself. The Reinvention Engines and their leaders are:
* AI and Data, led by Lan Guan, Accenture's Chief AI & Data Officer, which will build and scale AI and data capabilities globally; advance AI and data training across Accenture; and develop cutting-edge methods for designing, building and delivering the most modern AI and data foundation in the technology stack and embedding AI and data across the enterprise, powered by Accenture's Center for Advanced AI.
* Industry and Process, led by Jason Dess, which will build and scale even deeper industry and process expertise, establish industry and process training across Accenture, and develop AI-enabled methods to transform enterprises, such as AI-enabled ERP methods and ART, the company's proprietary reinvention methodology, powered by Accenture's Intelligent Operations Centers and Global Network Centers.
* Technology, led by Rajendra Prasad, which will build and scale advanced technology capabilities, advance technology training across Accenture, and develop the latest modern technology stacks, powered by Accenture Technology Centers.
Lastly, the design of Reinvention Services includes Client Success, a unit designed to ensure Accenture stays relentlessly focused on its clients, comprising:
* Commercial, led by Shaheen Sayed, Accenture's Chief Commercial Officer, which will ensure that Accenture sells clients what they truly need, brings the full strength of Accenture to every solution and creates win-win commercial models, as well as seeks and acts on client feedback and develops and supports client account leads.
* Offerings and Products, led by Senthil Ramani, Chief Offerings and Product Officer, which will oversee the development of differentiated offerings and products aligned to evolving client needs.
* Integrated Delivery Governance and Integrated Quality, led by David Golding, which will be responsible for delivering client outcomes through Accenture's global delivery capabilities and strengthening quality and consistency across engagements.
"As AI reshapes every industry, our clients want a partner that can help them reinvent--boldly, continuously and at speed," said Julie Sweet, chair and CEO, Accenture. "Our Reinvention Services leaders bring together the full breadth of Accenture to create solutions to our clients' most complex problems and deliver more value faster, while continuously building the most client-focused, AI-enabled great place to work for our people--our Reinventors."
"Reinvention Services is designed entirely around how our clients think about their business issues and organize their operations, enabling us to deliver reinvention for them at greater scale and impact," said Sharma. "This exceptional group of leaders integrates our industry depth, technology and AI expertise, ecosystem relationships, creativity and operational scale into one seamless experience for clients that drives measurable outcomes."
* * *
Forward-Looking Statements
Except for the historical information and discussions contained herein, statements in this news release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "should," "likely," "anticipates," "aspires," "expects," "intends," "plans," "projects," "believes," "estimates," "positioned," "outlook," "goal," "target" and similar expressions are used to identify these forward-looking statements. These statements are not guarantees of future performance nor promises that goals or targets will be met, and involve a number of risks, uncertainties and other factors that are difficult to predict and could cause actual results to differ materially from those expressed or implied. These risks include, without limitation, risks that: Accenture's results of operations have been, and may in the future be, adversely affected by volatile, negative or uncertain economic and geopolitical conditions and the effects of these conditions on the company's clients' businesses and levels of business activity; Accenture's business depends on generating and maintaining client demand for the company's solutions and services including through the adaptation and expansion of its solutions and services in response to ongoing changes in technology and offerings, and a significant reduction in such demand or an inability to respond to the evolving technological environment could materially affect the company's results of operations; risks and uncertainties related to the development and use of AI, including advanced AI, could harm the company's business, damage its reputation or give rise to legal or regulatory action; if Accenture is unable to match people and their skills with client demand around the world and attract and retain professionals with strong leadership skills, the company's business, the utilization rate of the company's professionals and the company's results of operations may be materially adversely affected; Accenture faces legal, reputational and financial risks from any failure to protect client and/or company data from security incidents or cyberattacks; the markets in which Accenture operates are highly competitive, and Accenture might not be able to compete effectively; if Accenture does not successfully manage and develop its relationships with its ecosystem partners or fails to anticipate and establish new alliances in new technologies, the company's results of operations could be adversely affected; Accenture's ability to attract and retain business and employees may depend on its reputation in the marketplace; Accenture's profitability could materially suffer due to pricing pressure, if the company is unable to remain competitive, if its cost-management strategies are unsuccessful or if it experiences delivery inefficiencies or fail to satisfy certain agreed-upon targets or specific service levels; changes in Accenture's level of taxes, as well as audits, investigations and tax proceedings, or changes in tax laws or in their interpretation or enforcement, could have a material adverse effect on the company's effective tax rate, results of operations, cash flows and financial condition; Accenture's results of operations could be materially adversely affected by fluctuations in foreign currency exchange rates; Accenture's debt obligations could adversely affect its business and financial condition; as a result of Accenture's geographically diverse operations and strategy to continue to grow in key markets around the world, the company is more susceptible to certain risks; if Accenture is unable to manage the organizational challenges associated with its size, the company might be unable to achieve its business objectives; Accenture might not be successful at acquiring, investing in or integrating businesses, entering into joint ventures or divesting businesses; Accenture's business could be materially adversely affected if the company incurs legal liability; Accenture's work with government clients exposes the company to additional risks inherent in the government contracting environment; Accenture's global operations expose the company to numerous and sometimes conflicting legal and regulatory requirements; if Accenture is unable to protect or enforce its intellectual property rights or if Accenture's solutions or services infringe upon the intellectual property rights of others or the company loses its ability to utilize the intellectual property of others, its business could be adversely affected; Accenture may be subject to criticism and negative publicity related to its incorporation in Ireland; as well as the risks, uncertainties and other factors discussed under the "Risk Factors" heading in Accenture plc's most recent Annual Report on Form 10-K and other documents filed with or furnished to the Securities and Exchange Commission. Statements in this news release speak only as of the date they were made, and Accenture undertakes no duty to update any forward-looking statements made in this news release or to conform such statements to actual results or changes in Accenture's expectations.
* * *
About Accenture
Accenture is a leading solutions and services company that helps the world's leading enterprises reinvent by building their digital core and unleashing the power of AI to create value at speed across the enterprise, bringing together the talent of our approximately 784,000 people, our proprietary assets and platforms, and deep ecosystem relationships. Our strategy is to be the reinvention partner of choice for our clients and to be the most client-focused, AI-enabled, great place to work in the world. Through our Reinvention Services we bring together our capabilities across strategy, consulting, technology, operations, Song and Industry X with our deep industry expertise to create and deliver solutions and services for our clients. Our purpose is to deliver on the promise of technology and human ingenuity, and we measure our success by the 360 value we create for all our stakeholders. Visit us at accenture.com.
* * *
Original text here: https://newsroom.accenture.com/news/2026/accenture-announces-reinvention-services-leadership
[Category: BizConsulting]
